Douglas Snider
About Douglas Snider
Douglas Snider serves as the Director of Pathology and Histology at Asklepios BioPharmaceutical, Inc., where he specializes in assay design and validation of immunohistochemistry and in situ hybridization techniques. He has an extensive background in toxicology and pathology, with previous roles at various academic and research institutions.
Work at Asklepios BioPharmaceutical
Douglas Snider currently holds the position of Director, Pathology and Histology at Asklepios BioPharmaceutical, Inc. (AskBio). He has been in this role since 2021, working in Research Triangle Park, North Carolina. In his current position, he focuses on advancing pathology and histology practices within the organization. His expertise includes assay design and validation, particularly in immunohistochemistry (IHC) and in situ hybridization (ISH) techniques.
Previous Experience in Pathology
Before joining Asklepios BioPharmaceutical, Douglas Snider worked as a Pathologist at EPL from 2020 to 2021 for 11 months in Research Triangle Park, North Carolina. He also served as a Postdoctoral Research Scientist and NIH Fellow at North Carolina State University from 2017 to 2020, and as an Anatomic and Toxicologic Pathology Instructor at Michigan State University from 2014 to 2017. His roles involved significant contributions to proof of concept studies and early preclinical research.
Education and Expertise
Douglas Snider has a strong educational background in veterinary medicine and toxicology. He earned a Doctor of Veterinary Medicine (DVM) degree from the University of Missouri-Columbia from 2002 to 2006. He completed a Master of Science in Toxicology with a minor in Pathology at Iowa State University. Additionally, he holds a Pharmaceutical Management Certificate from Cornell University and completed an Anatomic Pathology residency at Michigan State University from 2014 to 2017.
Background in Veterinary Medicine
Douglas Snider has extensive experience in veterinary medicine and diagnostics. He worked as a Veterinary Medical Officer at the USDA Animal and Plant Health Inspection Service (APHIS) from 2003 to 2006. He also served as a Veterinary Diagnostician in Toxicology at Iowa State University from 2011 to 2014. His background includes a focus on diagnostic toxicology and pathology, emphasizing process improvement and customer service.
Research and Technical Skills
Douglas Snider specializes in assay design and validation, particularly in immunohistochemistry (IHC) and in situ hybridization (ISH). He utilizes interdisciplinary bioengineering skills to address drug delivery challenges through in silico modeling prior to in vivo testing. His work also involves digital pathology, focusing on image analysis to quantify transduction efficiency and biodistribution at both compartmental and cell level resolution.